Neoadjuvant therapy for breast cancer.

CONCLUSIONS: The use of NT in Italy is limited and variable. There are no signs of greater use in hospitals with more advanced care. PMID: 31496430 [PubMed - as supplied by publisher]
Source: Tumori - Category: Cancer & Oncology Tags: Tumori Source Type: research